This priming underlies the heightened recruitment and activation of inflammatory myeloid cells and supports IFNAR blockade as a rational therapeutic approach to disrupt this early pathogenic axis in photosensitive autoimmunity. The gene discussed is IFNAR1; the disease is Autoimmunity.